Joel Greenblatt's position in Gilead Sciences is currently worth $25.1 Million. That's 0.25% of their equity portfolio (38th largest holding). The first Gilead Sciences trade was made in Q4 2010. Since then Joel Greenblatt bought shares 24 more times and sold shares on 29 occasions. The stake costed the investor $20.7 Million, netting the investor a gain of 21% so far.